Association between red cell distribution width and response to methotrexate in rheumatoid arthritis
Submitted: 31 July 2019
Accepted: 6 December 2019
Published: 10 April 2020
Accepted: 6 December 2019
Abstract Views: 1244
PDF: 662
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Similar Articles
- M. Todoerti, W. Maglione, E. Bernero, A. Bortoluzzi, M. Colaci, E. Galuppi, S. Paolino, R. Talarico, M. Cutolo, C. Ferri, F. Trotta, S. Bombardieri, C.M. Montecucco, L. Sinigaglia, Systematic review of 2008-2012 literature and update of recommendations for the use of methotrexate in rheumatic diseases, with a focus on rheumatoid arthritis , Reumatismo: Vol. 65 No. 5 (2013)
- M. Rossini, G. D'Avola, M. Muratore, N. Malavolta, F. Silveri, G. Bianchi, B. Frediani, G. Minisola, M. L. Sorgi, M. Varenna, R. Foti, G. Tartarelli, G. Orsolini, S. Adami, Regional differences of vitamin D deficiency in rheumatoid arthritis patients in Italy , Reumatismo: Vol. 65 No. 3 (2013)
- S.M. Günay, Z. Tuna, D. Oskay, Relationship between patient-reported and objective measurements of hand function in patients with rheumatoid arthritis , Reumatismo: Vol. 68 No. 4 (2016)
- F. Zare, M. Dehghan-Manshadi, A. Mirshafiey, The signal transducer and activator of transcription factors lodge in immunopathogenesis of rheumatoid arthritis , Reumatismo: Vol. 67 No. 4 (2015)
- F.M. Perrotta, E. Lubrano, New approved drugs for psoriatic arthritis , Reumatismo: Vol. 68 No. 2 (2016)
- M. Taraborelli, F. Inverardi, M. Fredi, A. Ceribelli, I. Cavazzana, A. Tincani, F. Franceschini, Anti-cyclic citrullinated peptide antibodies in systemic lupus erythematosus patients with articular involvement: a predictive marker for erosive disease? , Reumatismo: Vol. 64 No. 5 (2012)
- S. Russo, T. T. Mariani, R. Migliorini, A. Marcellusi, F. S. Mennini, The economic burden of musculoskeletal disorders on the Italian social security pension system estimated by a Monte Carlo simulation , Reumatismo: Vol. 67 No. 2 (2015)
- G. Lapadula, A. Marchesoni, F. Salaffi, R. Ramonda, C. Salvarani, L. Punzi, L. Costa, F. Caso, D. Simone, G. Baiocchi, C. Scioscia, M. Di Carlo, R. Scarpa, G. Ferraccioli, Evidence-based algorithm for diagnosis and assessment in psoriatic arthritis: results by Italian DElphi in psoriatic Arthritis (IDEA) , Reumatismo: Vol. 68 No. 3 (2016)
- M. Manara, L. Arcarese, G. Bianchi, V. Corbelli, O. Epis, R. Laurenti, A. Migliore, M. Muratore, A. Roncaglione, M. Rossini, M. Savo, L. Sinigaglia, The impact on disability of initial treatment with methotrexate in patients with rheumatoid arthritis: results from the MARI study , Reumatismo: Vol. 68 No. 4 (2016)
- M. Tofani, M. Nobilia, G. Culicchia, G. Esposito, A. Savona, I. Tashi, A. Ventura, G. Galeoto, The Italian version of rheumatoid arthritis pain scale (IT-RAPS): psychometric properties on community and clinical samples , Reumatismo: Vol. 71 No. 1 (2019)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
You may also start an advanced similarity search for this article.